⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TARS News
Tarsus Pharmaceuticals, Inc. Common Stock
Form 8-K
sec.gov
TARS
Tarsus Reports First Quarter 2026 Financial Results and Recent Business Achievements
globenewswire.com
TARS
Tarsus to Report First Quarter 2026 Financial Results on Wednesday, May 6, 2026
globenewswire.com
TARS
TP-03 (lotilaner ophthalmic solution) 0.25% Now Approved in China for the Treatment of Demodex Blepharitis, Triggering a $15M Milestone Payment to Tarsus
globenewswire.com
TARS
Tarsus to Participate in Upcoming Investor Conferences
globenewswire.com
TARS
Form 8-K
sec.gov
TARS
Tarsus Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Business Achievements
globenewswire.com
TARS
Tarsus Pharmaceuticals Appoints Renowned Biopharmaceutical Leader and Former Allergan CEO, David Pyott, to its Board of Directors
globenewswire.com
TARS
Tarsus to Report Fourth Quarter and Full Year 2025 Financial Results on Monday, February 23, 2026
globenewswire.com
TARS
TARS Demonstrates a Robot That Can Perform Hand Embroidery, Breaking Through a Key Automation Bottleneck in Flexible Manufacturing
prnewswire.com
TARS